Dark

Check out our Dark Pool Levels

AVCO
Avalon GloboCare Corp. Common Stock
stock NASDAQ

Inactive

Nov 10, 2022

0.4500USD-14.432%(-0.0759)583,959

Pre-market

0.00USD-100.000%(-0.53)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 4, 2022

09:10AM EST Avalon GloboCare Offers Year-End Business Update Of Selective Scientific, Clinical Programs Benzinga

09:00AM EST Company continues to expand and accelerate its R&D strategies for high-impact translational and clinical programs in the US and Europe GlobeNewswire Inc

Dec 22, 2021

09:04AM EST Avalon GloboCare Reports Chairman Converted Debt Into Common Stock Benzinga

09:00AM EST Avalon GloboCares Chairman Converts GlobeNewswire Inc

Dec 9, 2021

09:00AM EST Avalon GloboCare Advances AI-Enhanced Protein Design Technology GlobeNewswire Inc

Nov 11, 2021

11:25PM EST AVALON GLOBOCARE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: PR Newswire

Oct 14, 2021

09:20AM EDT -- Co-developed novel technology platform combining S-layer proteins and emulsomes for diverse applications in bio-delivery of drugs and genes with the University of Natural Resources and Life Sciences (BOKU) Vienna GlobeNewswire Inc

Oct 7, 2021

09:05AM EDT Avalon GloboCare's Advanced Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients Benzinga

09:00AM EDT Avalon GloboCare and University of Natural Resources and Life GlobeNewswire Inc

Sep 30, 2021

11:02AM EDT From BZ's Small Cap Healthcare Conference: Avalon Globocare Corp President & CEO, Dr. Davin Jin Begins Speaking Benzinga

10:52AM EDT Avalon GloboCare Aims to Revolutionize Cell Therapy Market with a Faster, Safer CAR-T Treatment Benzinga

Sep 29, 2021

01:28PM EDT Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients Benzinga

Sep 23, 2021

09:00AM EDT Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announcedthat it will be presenting at the Benzinga Healthcare Small Cap Conference, which is being held virtually from September 29 30, 2021. GlobeNewswire Inc

Sep 13, 2021

09:30AM EDT Sysorex (OTCQB: SYSX) (Sysorex or the Company), the preeminent, U.S.-based, publicly traded Ethereum mining and technologies company, today announced that it has elected William B. Stilley, III to the Companys Board of Directors and as Chair of the Boards Audit Committee. The Company also expanded the size of its Board to five directors and established its Audit Committee. GlobeNewswire Inc

Sep 8, 2021

12:11PM EDT AVALON GLOBOCARE INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Avalon GloboCare Corp. - AVCO Business Wire

Aug 4, 2021

10:26AM EDT UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCare Benzinga

09:00AM EDT A new collaboration among UPMC Hillman Cancer Center, the University of Pittsburgh and New Jersey-based biotechnology company Avalon GloboCare Corp. (NASDAQ: AVCO) aims to develop new cancer immunotherapy approaches and streamline manufacturing processes to bring these powerful treatments to cancer patients within days instead of weeks. GlobeNewswire Inc

Aug 2, 2021

11:41AM EDT UPMC Hillman Cancer Center Recently Announced University Of Pittsburg, Avalon GloboCare To Partner To Develop 'new cancer immunotherapy approaches and streamline manufacturing processes,' No Terms Disclosed Benzinga

Jul 1, 2021

09:01AM EDT Avalon GloboCare Announces Its Planned Acquisition Target, SenlangBio, Has Initiated First-In-Human Clinical Trial In Recurrent Brain Cancer Benzinga

09:00AM EDT Trial evaluating EphA2-targeted CAR T-cell therapy in recurrent glioblastoma, an urgent and significant unmet medical need with no standard of care treatment option GlobeNewswire Inc

Jun 28, 2021

09:15AM EDT Avalon GloboCare Says Generated Revenues Of $1.2M For Three Months Ended Mar. 31, Sees FY21 Sales $5M-$7M Benzinga

09:05AM EDT Previously Announced Execution of Definitive Agreement to Acquire SenlangBio GlobeNewswire Inc

Jun 14, 2021

12:49PM EDT Avalon GloboCare Adds Cell Therapy-Based Candidates For Cancer With SenlangBio Acquisition: Highlights Benzinga

09:04AM EDT Avalon GloboCare Announces Execution Of Purchase Agreement For Acquisition Of SenlangBio In All Stock Transaction; Will Sell 15.6% Equity Interest In SenlangBio To Institutional Healthcare Investor For $30M Benzinga

09:00AM EDT SenlangBio, a world-class cell therapy company, has developed a robust pipeline which includes 15 autologous and universal (off-the-shelf) CAR-T and CAR-T cell therapy candidates targeting hematologic malignancies and solid tumors GlobeNewswire Inc

Jun 11, 2021

09:00AM EDT Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announcedthat it will be presenting at the Noble Capital Markets Investor Forum during the 16th Annual World Stem Cell Summit to be held virtually on June 14-18, 2021. GlobeNewswire Inc

Jun 8, 2021

09:02AM EDT Avalon GloboCare Says Will Present Its S-Layer, QTY Code Breakthrough Technology Platforms At World Stem Cell Summit Benzinga

09:00AM EDT Avalon GloboCare To Present Its S-Layer and QTY Code Breakthrough GlobeNewswire Inc

Mar 29, 2021

09:27AM EDT UPDATE: In Connection With Agreement, Avalon And UPMC Hillman Center Will Advance AVA-011 And Other FLASH-CAR Candidates Using The PMAPsys Platform Benzinga

09:26AM EDT Avalon GloboCare Announces Collaboration With University Of Pittsburgh Medical Center Hillman Cancer Center To Advance Clinical Development Of Cellular Immunotherapies Using = FLASH-CAR Platform Benzinga

09:25AM EDT -- Development of FLASH-CAR RNA-based cellular therapies includes utilization of Avalons new Point-of-Care Modular Autonomous Processing System (PMAPsys) -- First FLASH-CAR candidate, AVA-011, on-track for clinical study in B-cell lymphoblastic leukemia and non-Hodgkins lymphoma patients GlobeNewswire Inc

Mar 22, 2021

09:04AM EDT Avalon GloboCare Shares Spike Higher; Co Says Expands Co-Development Program With MIT To Combat Cancer Metastasis Benzinga

09:00AM EDT -- Dual cutting edge technology approach using CRISPR-based genome editing and QTY code-based truncated chemokine receptors GlobeNewswire Inc

Feb 9, 2021

10:31AM EST Siyata Mobile Appoints Peter Goldstein as Chairman and Adds GlobeNewswire Inc

Dec 30, 2020

09:07AM EST Avalon GloboCare, University Of Natural Resources And Life Sciences Expand Partnership And Accelerate Development Of S-Layer Based Vaccines, Cellular Therapeutics Benzinga

09:00AM EST Avalon GloboCare and University of Natural Resources and Life GlobeNewswire Inc

Oct 22, 2020

08:38AM EDT Avalon GloboCare And Adial Pharmaceuticals Announce A Strategic Collaboration For The Global Distribution Of Coronavirus Point Of Care Antibody Rapid Test Devices Benzinga

08:33AM EDT UPDATE: Under agreement, Adial Grants Avalon Non-Exclusive, Sub-Distribution Rights Worldwide For The FaStep COVID-19 IgG/IgM Rapid Test Device And The Assure/EcoStep COVID-19 IgG/IgM Rapid Test Device, POC COVID-19 Antibody Tests Benzinga

08:31AM EDT Avalon GloboCare And Adial Pharmaceuticals Announce Collaboration For Global Distribution of COVID-19 Point-Of-Care Antibody Rapid Test Devices Benzinga

08:30AM EDT Avalon GloboCare and Adial Pharmaceuticals Announce Strategic GlobeNewswire Inc

Oct 1, 2020

09:25AM EDT Avalon GloboCare Offers Clinical Updates On Its CAR-T Immuno-Oncology, Allogeneic Mesenchymal Stromal Cell Therapy Programs Benzinga

09:00AM EDT Avalon GloboCare Provides Clinical Updates on Its CAR-T GlobeNewswire Inc

Sep 3, 2020

11:11AM EDT Avalon GloboCare CEO to Participate in Virtual Panel: GlobeNewswire Inc

09:01AM EDT Avalon GloboCare Announces Mesenchymal Stromal Cell Therapeutic Platform For COVID-19, Acute Graft Cersus Host Disease Benzinga

09:00AM EDT -- Progressing planned pre-clinical testing for innovative allogeneic MSC-based cellular therapy for both COVID-19 and aGVHD GlobeNewswire Inc

Aug 19, 2020

11:03AM EDT Why Avalon Globocare's Stock Is Trading Higher Today Benzinga

09:07AM EDT Avalon GloboCare Enters Commercialization And Distribution Agreement With Cellex For COVID-19 Antibody Rapid Test Kit RTTNews

09:01AM EDT Avalon GloboCare Announces Commercialization and Distribution Agreement with Cellex for COVID-19 Antibody Rapid Test Kit Benzinga

09:00AM EDT Avalon GloboCare Announces Commercialization and Distribution GlobeNewswire Inc

Aug 12, 2020

12:03PM EDT Avalon Globocare shares are trading higher after the company announced it would expand its AVA-Trap program to treat coronavirus and CAR-T related cytokine storms. Benzinga

09:06AM EDT Avalon GloboCare Expands AVA-Trap Program To Treat Coronavirus And CAR-T Related Cytokine Storms Benzinga

09:00AM EDT Avalon GloboCare Expands AVA-Trap Program to GlobeNewswire Inc

Jul 13, 2020

09:01AM EDT Avalon GloboCare Offers Update On Its 4 Scientific Research, Clinical Development Programs Benzinga

09:00AM EDT Avalon GloboCare Provides Updates on its Lead Scientific and GlobeNewswire Inc

Share